Skip to main content
. Author manuscript; available in PMC: 2013 Aug 8.
Published in final edited form as: J Drug Issues. 2010 Oct;40(4):819–839. doi: 10.1177/002204261004000404

Table 2.

CASPAR Qualitative Implementation Analysis Participants

Organization Status Primary Funding
Source*
Total
Capacity
Acreditation** Counselors
Interviewed
Directors
Interviewed
Project A
  Site 1 Non-profit, Private State 270 None 2 1
  Site 2 Non-profit, Private State 300 None 2 1
  Site 3 Non-profit, Private Private insurance 102 State, JCAHO 1 1
  Site 4 Non-profit, Private Private insurance 100 JCAHO 2 1
  Site 5 Non-profit, Private Private insurance 140 JCAHO 1 2
  Site 6 For-profit, Private Private insurance 180 State 3 1
  Site 7 For-profit, Private Private insurance 106 None 2 0***
Site 8 Non-profit, Public State, Public managed
care
270 CARF 1 1
   Total 14 8
Project B
  Site 9 Non-profit, Private Self-pay 85 State 1 2
  Site 10 Non-profit State 40 None 2 2
  Site 11 Non-profit State 320 None 2 1
  Site 12 Non-profit State 275 JCAHO 5 2
  Site 13 Non-profit State 60 None 1 1
  Site 14 Non-profit Self-pay, State 48 JCAHO, State 2 1
  Site 15 Non-profit State 99 None 1 3
  Site 16 Non-profit State 40 None 2 1
   Total 16 13

NOTE: Program characteristics were collected as part of the replication projects with using the Addiction Treatment Inventory (ATI; Carise et al., 2000)

*

Programs were asked about the percent of their funding that came from different sources; primary funding source is defined as the source (or sources) comprising the majority of funding (>50%).

**

State accreditation for Project A sites were granted from the Pennsylvania Bureau of Drug & Alcohol Programs (BDAP); State accreditation for Project B sites were granted from the New Jersey Division of Addiction Services (DAS).

***

Sites 6 and 7 in Project A had the same director.